Interventricular Conduction Delay on Echocardiography
Interventricular conduction delay (IVCD) on echocardiography indicates ventricular dyssynchrony—a mechanical delay between right and left ventricular contraction that signals impaired electromechanical coupling and predicts worse outcomes in heart failure patients.
What IVCD Represents
IVCD reflects prolonged interventricular and intraventricular conduction that causes regional mechanical delay within the left ventricle. This electrical-mechanical disconnect results in 1, 2:
- Reduced ventricular systolic function
- Altered myocardial metabolism
- Functional mitral regurgitation
- Adverse remodeling with ventricular dilatation
The most common form is left bundle branch block (LBBB), though IVCD encompasses any pattern of delayed ventricular activation 1, 2.
Clinical Significance and Prognosis
IVCD is a powerful predictor of mortality and morbidity. Both QRS duration and dyssynchrony have been identified as independent predictors of worsening heart failure, sudden cardiac death, and total mortality 1, 2. In acute coronary syndrome patients specifically, IVCD carries substantially elevated cardiac mortality risk even after adjusting for age and comorbidities 3.
Prevalence in Heart Failure
- Occurs in approximately one-third of patients with advanced heart failure 1, 2, 4
- Among heart failure patients with LVEF ≤35%, 41% have QRS duration ≥120 ms 5
- 34% have LBBB or other IVCD patterns 5
Echocardiographic Assessment
Interventricular mechanical delay (IVMD) >40-50 ms is considered clinically significant dyssynchrony 6, 7. This is measured as:
- Time difference between left and right ventricular pre-ejection periods
- Can be assessed using standard pulsed Doppler or tissue Doppler imaging (TDI)
- Correlates moderately with electrical measures (QRS duration) but not perfectly 6, 8
Critical Pitfall
QRS duration alone is NOT a reliable marker for mechanical dyssynchrony in all patients. Research shows that 25-44% of patients may be misclassified by ECG criteria alone 6. Some patients with normal QRS have significant mechanical dyssynchrony, while others with wide QRS lack mechanical asynchrony 6, 7. Therefore, echocardiographic confirmation is essential 9.
Therapeutic Implications
The presence of IVCD with heart failure identifies candidates for cardiac resynchronization therapy (CRT). The strongest Class I indication exists for patients with 1, 2:
- LVEF ≤35%
- LBBB pattern with QRS ≥150 ms
- NYHA Class II-IV symptoms
- Sinus rhythm
- Optimal medical therapy
CRT in appropriately selected patients provides:
- 24-36% mortality reduction 1, 2, 4
- ~30% decrease in hospitalizations 1, 2
- Improved exercise capacity and quality of life 1, 2
- Favorable reverse remodeling 1, 2
Modern Approach
Recent evidence suggests that intraoperative IVCD measurement can guide optimal CRT strategy between biventricular pacing versus conduction system pacing. If the RV-to-LV sensed interval is ≥100 ms, standard positioning is appropriate; if <100 ms, conduction system pacing may be superior 10. This approach increases CRT responder rates from 70% to >90% 10.
Structural Heart Disease Evaluation
Echocardiography is indicated in all patients with IVCD to exclude underlying structural heart disease 9. IVCD may be a harbinger of occult structural or ischemic disease, including:
- Cardiomyopathy (dilated, hypertrophic, infiltrative)
- Valvular disease
- Congenital anomalies
- Ischemic heart disease 9
The 2019 ACC/AHA/HRS guidelines endorse echocardiography as appropriate for symptoms potentially caused by conduction disorders, and excluding structural disease in all LBBB patients is prudent given the elevated risk profile 9.